课题基金 / 基金详情

INVESTIGATIONS ON THE REGULATION OF INTERVERTEBRAL DISC CELL MATRIX METALLOPROTEINASES

INVESTIGATIONS ON THE REGULATION OF INTERVERTEBRAL DISC CELL MATRIX METALLOPROTEINASES
椎间盘细胞基质金属蛋白酶调控的研究
批准号:
nhmrc : 211266
负责人:
Dr James Melrose
金额:
$22.09万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2002
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2002-01-01 至 2004-12-31

项目摘要

项目成果

Dr James Melrose的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Degeneration of the intervertebral disc is a painful disabling condition with major socioeconomic consequences. Medical problems associated with disc degeneration and back-pain, of sufficient severity to warrant consultation with a physician, are experienced by 90% of the population some time during their lives. In man, back pain increases in incidence in the third and fourth decades of life, peaks in the fifties and declines thereafter. Changes in population demographics indicate this problem will increase in severity over the next few decades. American Bureau of Census data indicate that between 1990 to 2010 the number of people >45 years will increase from 82 to 124 million, the number of elderly in emerging countries will also increase between 200 to 400% in the next 30 years. In the United States, back-pain is the second most common reason that people visit a physician and medical conditions related to back-pain account for more hospitalisations than any other musculoskeletal disorder. Despite its high incidence, associated problems of incapacity and economic implications, costed at $100 million per annum in Australia in 1992, and US$100 billion globally in 1999-2000 (Dorland Data Networks, PA, USA) the causes of low back-pain are still poorly understood. Disc disease is responsible for 23-40% of all cases of low back-pain. The management of discogenic low back-pain is currently empirical, directed either toward life-style changes to minimise symptomatology or to surgical resection or spinal arthrodesis to restrict articulation. Based on our recent findings and those of colleagues over the last 16 years, it is our strong conviction that it should be possible with a better understanding of disease mechanisms and with the use of modern technologies to inhibit, reverse or ideally prevent disc degeneration. Without such basic research there will be no scientific foundation upon which prospective therapies may be based.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mesenchymal Progenitor cells and intervertebral disc repair
  • 批准号:
    nhmrc : 1004032
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $50.29万
  • 财政年份:
    2011
  • 负责人:
    Dr James Melrose
  • 依托单位:
Stem cell treatment for tendon degeneration
  • 批准号:
    nhmrc : 570922
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $45.69万
  • 财政年份:
    2009
  • 负责人:
    Dr James Melrose
  • 依托单位:
Proteoglycan metabolism in tendon degeneration
  • 批准号:
    nhmrc : 402626
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $31.28万
  • 财政年份:
    2006
  • 负责人:
    Dr James Melrose
  • 依托单位:
Pathobiology of the small leucine rich repeat proteoglycans in cartilage, intervertebral disc and tendon degeneration
  • 批准号:
    nhmrc : 352562
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $34.45万
  • 财政年份:
    2005
  • 负责人:
    Dr James Melrose
  • 依托单位:
海外基金